Aroa Biosurgery Director Ups Stake in Company
Company Announcements

Aroa Biosurgery Director Ups Stake in Company

Aroa Biosurgery Ltd (AU:ARX) has released an update.

Dr. Catherine Mohr, a director of Aroa Biosurgery Limited, has increased her direct and indirect shareholdings through an on-market trade, acquiring 436,364 fully paid ordinary shares at a cost of $163,453.67. This transaction, dated September 30, 2024, brings Dr. Mohr’s total direct and indirect interest in the company to 647,050 shares, following her previously held 210,686 options exercisable at $0.87, set to expire on November 13, 2027.

For further insights into AU:ARX stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App